Aloperine Activates the PI3K/Akt Pathway and Protects Against Coronary Microembolisation-Induced Myocardial Injury in Rats

Conclusions: ALO can inhibit cardiomyocyte apoptosis and consequently attenuate CME-induced myocardial injury. These functions are realised by activating PI3K/Akt signalling pathway.Pharmacology 2019;104:90 –97
Source: Pharmacology - Category: Drugs & Pharmacology Source Type: research